Market Cap: $477.61M
CC
Cerus Corporation
CERS
NASDAQ (NASDAQ Global Market)USD
Market Cap: $477.61M
Cerus Corporation Maintains Focus on Blood Safety Amid Economic Volatility In light of recent fluctuations in U.S. stock futures, Cerus Corporation remains steadfast in its commitment to enhancing blo…
Cerus Corporation's Growth in Blood Safety Solutions Drives Future Potential Cerus Corporation (NASDAQ:CERS) reports a robust financial outcome for the fourth quarter of 2026, emphasizing its role in…
## Cerus Corporation: Advancing Blood Safety Solutions Amid Strong Financial Performance Cerus Corporation continues to demonstrate its growth trajectory following the recent release of its Q4 earning…
### Cerus Corporation Prepares for Significant Earnings Report Amidst Innovations in Blood Safety Technologies Cerus Corporation stands on the brink of revealing its quarterly earnings report on March…
Cerus Corporation Poised to Showcase Advances in Blood Safety Technology Amid Earnings Anticipation Cerus Corporation prepares for the release of its quarterly earnings report, slated for March 2, 202…
Cerus Corporation: Advancements in Blood Safety Technology Cerus Corporation continues to lead the field of blood safety technology with its innovative INTERCEPT Blood System, which is designed to red…
Cerus Corporation Enhances Blood Safety with Innovative Technology Cerus Corporation, a leader in blood safety technology, announces a significant advancement in its INTERCEPT Blood System, aimed at f…
Cerus Corporation’s Commitment to Blood Safety and Innovation Cerus Corporation, based in Concord, California, continues to position itself as a leader in ensuring the safety of the global blood suppl…
Cerus Corporation Prepares for Financial Results Announcement Amidst Innovative Blood Safety Advances Cerus Corporation, based in Concord, California, is set to release its fourth quarter and full-yea…
Cerus Corporation Reports Strong Revenue Growth Amid Expanding Product Lines Cerus Corporation demonstrates robust growth in its preliminary product revenues for the fourth quarter and full year of 20…
Cerus Corporation Reports Strong Growth in Product Revenues for 2024 Cerus Corporation announces impressive preliminary product revenues for the fourth quarter and full year of 2024, indicating a tota…
Ensuring Blood Safety: Cerus Corporation's Commitment to Pathogen Reduction Technologies Cerus Corporation, headquartered in Concord, California, reiterates its dedication to safeguarding the global b…